Pharmaceuticals

Plasma Fractionation Market Developments And Opportunities Across 2026–2030

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Plasma Fractionation Market Grow Between 2026 And 2030?

The plasma fractionation market has experienced significant expansion recently. This market is projected to increase from $34.14 billion in 2025 to $37.63 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 10.2%. Historically, this expansion was driven by factors such as an escalating demand for immunoglobulins, a higher incidence of hematological disorders, continuous technological improvements in plasma fractionation, the enlargement of hospital and clinical facilities, and greater public understanding of plasma-derived treatments.

The plasma fractionation market is projected for substantial expansion in the upcoming years. This market is anticipated to reach $55.85 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.4%. The expansion throughout the forecast period can be attributed to the rising adoption of precision medicine, the incorporation of AI into plasma manufacturing, the broadening of global biopharmaceutical collaborations, increased investments in plasma collection centers, and the development of new plasma-derived therapies. Prominent trends for the forecast period include advanced plasma fractionation techniques, diversification of biopharmaceutical products, enhanced quality control and regulatory compliance, the expansion of contract manufacturing organizations (CMOs/CDMOs), and optimized supply chains for plasma products.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Factors Are Influencing The Growth Of The Plasma Fractionation Market?

A rising incidence of chronic illnesses is anticipated to drive expansion in the plasma fractionation market in the future. Chronic illnesses are defined as conditions persisting for a year or longer, necessitating continuous medical care, with examples encompassing ailments like heart disease, cancer, and diabetes. Providing plasma products for the treatment of individuals with chronic conditions decreases illness, enhances their quality of life, and offers economic benefits, thereby boosting the demand for plasma fractionation. As an illustration, GOV.UK, a UK-based non-profit government body, reported in March 2025 that the prevalence of type 2 diabetes among adults, specifically those aged 17 and over in England, was recorded by GPs as 7.0% in March 2024, representing an increase from 6.8% in March 2023. Consequently, the growing prevalence of chronic diseases across all age groups is projected to stimulate the growth of the plasma fractionation market.

Which Segment Classifications Are Used In The Plasma Fractionation Market Segment Analysis?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

What Trends Are Influencing The Evolution Of The Plasma Fractionation Market?

Major companies in the market are implementing new technologies, including high-tech facility processes that transform donated human plasma into crucial medicines, utilizing advanced technology to enhance both efficiency and safety. For instance, in March 2023, CSL Behring, a German-based company, launched a new $470 million plasma fractionation facility. This facility employs cutting-edge technology to improve the efficiency and safety of plasma processing, thereby ensuring higher quality and more reliable medicines. By expanding the supply of these vital medicines, the facility helps to satisfy the rising demand, guaranteeing greater patient access to life-saving treatments. With its advanced automation and self-cleaning systems, it minimizes the risk of contamination and improves overall hygienic conditions, consequently enhancing patient safety.

Which Firms Are Contributing To The Plasma Fractionation Market Ecosystem?

Major companies operating in the plasma fractionation market are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Get The Full Plasma Fractionation Market Report:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Region Leads The Plasma Fractionation Market In Terms Of Market Share?

North America was the largest region in the plasma fractionation market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Plasma Fractionation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Browse Through More Reports Similar to the Global Plasma Fractionation Market 2026, By The Business Research Company

Plasma Fractionation Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Plasma Powder Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Blood Plasma Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795